Many thanks to the organisers of #SITCspringscientific25, a fantastic few days of discussing all things cellular therapy in San Diego ππ»
@sitcancer.bsky.social
@drjonlim.bsky.social
UK π¬π§ contingent at #SITCSpringScientific25!
What a stimulating meeting - fully dedicated to discussing everything cell therapy for solid tumours. Fantastic faculty & programme + excellent venue!
Feeling super inspired! π
Thank you @sitcancer.bsky.social & the organisers!
@maxjulve.bsky.social
Eagerly awaiting the full publication in press @naturemedicine.bsky.social after this presentation by @jasonlukemd.bsky.social at #SITCSpringScientific25!
IMA203: TCR-T against PRAME in advanced melanoma.
@sitcancer.bsky.social
#SITCSpringScientific25
Now onto TCR-T - lots of discussions re: what the best technologies are to predict neoAg-reactive TCRs (private/public).
Great presentation from Wouter Scheper - @nkinl.bsky.social leading the way once again!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
#SITCSpringScientific25
We are only at beginning of TIL therapy - we know these are highly personalised, polyclonal product consisting of CD8 & CD4 T cells, but currently still a βblack boxβ.
So much more to do!
@sitcancer.bsky.social
π Reminded of a nice review π
jitc.bmj.com/content/jitc...
Thank you βΊοΈ! Great venue & fantastic programme! Looking forward.
#SITCSpringScientific25
Welcome to San Diego Dr. Lim, weβre thrilled to have you at #SITCSpringScientific25!
This program is packed with cutting-edge research and insights from leaders in the field!
#TILtherapy #CellTherapy #CanSky
Excited to be here in San Diego πΊπΈ for #SITCSpringScientific25 focussing on cellular therapy for solid tumours.
π To kickstart, we hear keynote from @haanenjohn.bsky.social @nkinl.bsky.social sharing experience from academia-led work on TILs - from basic to translational research to clinical trials!